Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.
Reneo Pharmaceuticals Q2 EPS $(0.50) Down From $(0.43) YoY
Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.
Related Posts
Preview: Bank of America’s Earnings
October 16, 5:00 PM
Bank of America (NYSE:BAC) is set to give its latest quarterly earnings report on Tuesday, 2023-10-17. Here’s what…
Turquoise Hill Resources Q2 EPS $0.41 Beats $0.36 Estimate, Sales $402.04M Miss $411.87M Estimate
August 4, 5:25 PM
Turquoise Hill Resources (NYSE:TRQ) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.36 by 13.89 percent. This is a 14.58 percent decrease over earnings of $0.48 per share
Cognizant and Cambridge University Team Up for AI-Driven Education Revolution
January 3, 5:08 AM
Renewed five-year relationship will see Cognizant and Cambridge drive digital transformation and leverage AI technology
LONDON, Jan. 3, 2024 /CNW/ -- Cambridge University Press &